Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VLDL secretion is the process by which the liver assembles and releases VLDL particles into the bloodstream for the transport of endogenous triglycerides to peripheral tissues. It is a crucial aspect of lipid metabolism and homeostasis, and its dysregulation is associated with various metabolic disorders including hypertriglyceridemia, atherosclerosis, and non-alcoholic fatty liver disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Very Low-Density Lipoprotein Secretion (VLDL Secretion).